Filings

13 documents · 21 matches

1. RGEN REPLIGEN CORP 10-Q 2026-10-30

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   continue to monitor the effects of tariffs implemented by the Trump administration and the potential imposition of modified or additional tariffs.
   1 match in this document Show context Copy citation

2. RGEN REPLIGEN CORP 10-Q 2026-07-29

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   continue to monitor the effects of tariffs implemented by the Trump administration and the potential imposition of modified or additional tariffs.
   1 match in this document Show context Copy citation

3. RGEN REPLIGEN CORP 10-Q 2026-05-06

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs implemented by the Trump administration and the potential imposition of modified or additional tariffs. On February 20, 2026, the U.S. Supreme
   2 matches in this document Show context Copy citation

4. RGEN REPLIGEN CORP 10-K 2026-02-26

   Item 1A. Risk Factors

   tariff exposure and closely monitor trade policy developments. However, recent litigation challenging the legality of certain tariffs before the U.S. Supreme
   5 matches in this document Show context Copy citation

5. RGEN REPLIGEN CORP 10-Q 2025-11-04

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   continue to monitor the effects of tariffs implemented by the Trump administration and the potential imposition of modified or additional tariffs.
   2 matches in this document Show context Copy citation

6. RGEN REPLIGEN CORP 10-Q 2025-08-07

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   continue to monitor the effects of tariffs implemented by the Trump administration, and the potential imposition of modified or additional tariffs.
   2 matches in this document Show context Copy citation

7. RGEN REPLIGEN CORP 8-K 2026-10-30

   tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S. Securities and Exchange
   1 match in this document Show context Copy citation

8. RGEN REPLIGEN CORP 8-K 2026-10-27

   tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S. Securities and Exchange
   1 match in this document Show context Copy citation

9. RGEN REPLIGEN CORP 8-K 2026-07-28

   tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S. Securities and Exchange
   1 match in this document Show context Copy citation

10. RGEN REPLIGEN CORP 8-K 2026-05-05

    price; the impact of tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S.
    1 match in this document Show context Copy citation

11. RGEN REPLIGEN CORP 8-K 2026-02-24

    tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S. Securities and Exchange
    1 match in this document Show context Copy citation

12. RGEN REPLIGEN CORP 8-K 2025-10-28

    tariffs on our business, and other risks and uncertainties detailed in Repligen’s filings with the U.S. Securities and Exchange
    1 match in this document Show context Copy citation

13. RGEN REPLIGEN CORP 8-K 2025-07-29

    which is more than offset by strength elsewhere in the portfolio. Guidance also incorporates a modest impact from tariff surcharges.
    2 matches in this document Show context Copy citation